77548

Evaluation of Peptidomimetics Looking for New Cathepsin K Inhibitors

Favorite this paper

Cysteine proteases are members of the papain-like peptidase family. These enzymes are involved in different physiological processes, in addition to be related to different pathologies, being recognized for decades as powerful therapeutic targets for the treatment of several diseases. Cathepsin K (CatK) is a lysosomal cysteine protease highly expressed in osteoclasts and responsible for the bulk degradation of the collagenous bone matrix thus an ideal target for antiosteoporotic drug development. Epoxide derivatives are described as potent cysteine proteases inhibitor. We have been investigating the inhibitory activity of some synthetic compounds in CatK searching new inhibitor of this enzyme. In the present work we show the inhibitory activity against CatK of new peptidomimetics (epoxy-α-aciloxicarboxamidas) in CatK. All assays were performed at room temperature in 0.1 M sodium acetate (pH 5.5), containing 2.5 mM DTT and 2.5 mM EDTA. Inhibition of CatK was determined in a spectro-fluorometric assay using the fluorogenic substrate Z-Phe-Arg-MCA, was recorded with a Fluorimeter (λex = 380 nm and λem = 450 nm). The IC 50 values were determined allowing to study their relation of structural activity.